Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Triptorelin is a peptide formulation for injection that was developed mainly for the treatment of advanced metastatic prostate cancer. Furthermore, other indications developed subsequently include the treatment of uterine fibroids (a benign tumor of muscle tissues in the uterus), endometriosis (proliferation of endometrial tissue, the mucous membrane that lines the uterine wall outside the reproductive tract) prior to surgery or when surgery is not deemed appropriate, as well as early onset puberty and female infertility (in vitro fertilization). Other modalities of triptorelin such as triptorelin acetate, triptorelin pamoate and triptorelin embonate are also used for prostate cancer treatment.
Market Dynamics
Triptorelin market is expected to witness lucrative growth opportunities during forecast period, owing to increasing incidence of prostate cancer and salivary gland cancer and increasing prevalence of central precocious puberty among the young patients below age eight and nine years, worldwide. For instance, according to National Organization for Rare Disorders (NORD), 2016 data findings, Central Precocious Puberty (CPP), accounted for 1 to 5 in 10,000 children with a female to male ratio of about 20:1, in U.S.
In March 2017, Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK, in coordination with fourteen other European regulatory agencies approved a new indication of Decapeptyl (triptorelin). According to these new indication, Decapeptyl (triptorelin) will be used as adjuvant treatment in combination with tamoxifen or aromatase inhibitor for endocrine-responsive early-stage breast cancer in women at high-risk of recurrence who are confirmed as pre-menopausal after completion of chemotherapy. This would enhance the revenue for growth for triptorelin market, during forecast period.
Furthermore, higher efficacy and tolerability of triptorelin in suppression of gonadotropin secretion in prostate cancer and precocious puberty is increasing adoption of triptorelin in the market.
Key features of the study:
This report provides in-depth analysis of triptorelin market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global triptorelin market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Key companies covered as a part of this study include Ipsen, Bachem, Ferring Pharmaceuticals Pvt Ltd., Chengdu Tiantaishan pharmaceutical Co., Ltd., Tecnofarma, Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd. (Actavis Specialty Pharmaceuticals Co.), Debiopharm Group, and Arbor Pharmaceuticals, LLC.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global triptorelin market report caters to various stakeholders in this industry including investors, suppliers, triptorelin based product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the triptorelin market.
Detailed Segmentation:
Global Triptorelin Market, By Drug Type:
Triptorelin Pamoate
Triptorelin Acetate
Triptorelin Embonate
Global Triptorelin Market, By Application:
Prostate Cancer
Radical Prostatectomy
Endometriosis
Salivary Gland Cancer
Central Precocious Puberty
Global Triptorelin Market, By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Triptorelin Market, By Geography:
North America
By Country:
U.S.
Canada
By Drug Type:
Decapeptyl SR
Trelstar
Decapeptyl SR
Gonapeptyl depot
Salvacyl
Triptorelin pamoate
Triptorelin acetate
Triptorelin embonate
By Application
Prostate Cancer
Radical Prostatectomy
Endometriosis
Salivary Gland Cancer
Central Precocious Puberty
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Europe
By Country:
Germany
France
Italy
UK
Spain
Russia
Rest of Europe
By Drug Type:
Triptorelin pamoate
Decapeptyl SR
Trelstar
Triptorelin acetate
Decapeptyl SR
Gonapeptyl depot
Triptorelin embonate
Salvacyl
By Application
Prostate Cancer
Radical Prostatectomy
Endometriosis
Salivary Gland Cancer
Central Precocious Puberty
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Asia Pacific
By Country:
China
India
Japan
South Korea
Australia
Rest of Asia Pacific
By Drug Type:
Triptorelin pamoate
Decapeptyl SR
Trelstar
Triptorelin acetate
Decapeptyl SR
Gonapeptyl depot
Triptorelin embonate
Salvacyl
By Application
Prostate Cancer
Radical Prostatectomy
Endometriosis
Salivary Gland Cancer
Central Precocious Puberty
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Drug Type:
Triptorelin pamoate
Decapeptyl SR
Trelstar
Triptorelin acetate
Decapeptyl SR
Gonapeptyl depot
Triptorelin embonate
Salvacyl
By Application
Prostate Cancer
Radical Prostatectomy
Endometriosis
Salivary Gland Cancer
Central Precocious Puberty
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Latin America
By Country:
Brazil
Argentina
Mexico
Rest of Latin America
By Drug Type:
Triptorelin pamoate
Decapeptyl SR
Trelstar
Triptorelin acetate
Decapeptyl SR
Gonapeptyl depot
Triptorelin embonate
Salvacyl
By Application
Prostate Cancer
Radical Prostatectomy
Endometriosis
Salivary Gland Cancer
Central Precocious Puberty
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Africa
By Country:
South Africa
Central Africa
North Africa
By Drug Type:
Triptorelin pamoate
Decapeptyl SR
Trelstar
Triptorelin acetate
Decapeptyl SR
Gonapeptyl depot
Triptorelin embonate
Salvacyl
By Application
Prostate Cancer
Radical Prostatectomy
Endometriosis
Salivary Gland Cancer
Central Precocious Puberty
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Company Profiles
Ipsen *
Company Overview
Product Portfolio
Financial Performance
Recent Developments
Strategies
Bachem
Ferring Pharmaceuticals Pvt Ltd.
Chengdu Tiantaishan pharmaceutical Co., Ltd.
Tecnofarma
Reddy’s Laboratories Ltd.
Teva Pharmaceutical Industries Ltd. (Actavis Specialty Pharmaceuticals Co.)
Debiopharm Group
Arbor Pharmaceuticals, LLC
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Drug Type
o Market Snippet, By Application
o Market Snippet, By Distribution Channel
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Regulatory Scenario
o Market Trends
o Epidemiology
o New Product Approvals/Launch
o Mergers/ Acquisition
o Strategic Collaborations
o PEST Analysis
4. Global Triptorelin Market, By Drug Type, 2016 - 2026 (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Triptorelin pamoate
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Triptorelin acetate
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Triptorelin embonate
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
5. Global Triptorelin Market, By Application, 2016 - 2026 (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Prostate Cancer
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Radical Prostatectomy
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Endometriosis
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Salivary Gland Cancer
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Central Precocious Puberty
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
6. Global Triptorelin Market, By Distribution Channel, 2016 - 2026 (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Hospital Pharmacy
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Retail Pharmacy
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Online Pharmacy
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
7. Global Triptorelin Market, By Regions, 2016 - 2026 (US$ Million)
o Introduction
o Market Share Analysis, By Region, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, For Regions, 2017 - 2026
o North America
o Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• U.S.
• Canada
o Europe
o Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• China
• Japan
• India
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
o Latin America
o Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
o Africa
o Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• North Africa
• Central Africa
• South Africa
o Middle East
o Market Size and Forecast, By Drug Type, 2016 - 2026 (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• GCC Countries
• Israel
• Rest of Middle East
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
o Ipsen
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
o Bachem
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
o Ferring Pharmaceuticals Pvt Ltd.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
o Chengdu Tiantaishan pharmaceutical Co., Ltd.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
o Tecnofarma
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
o Dr. Reddy's Laboratories Ltd.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
o Teva Pharmaceutical Industries Ltd. (Actavis Specialty Pharmaceuticals Co.)
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
o Debiopharm Group
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
o Arbor Pharmaceuticals, LLC
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
o Analyst Views
9. Section
o References
o Analyst Views
o Research Methodology
o About Us and Sales Contact
*Browse 26 market data tables and 21 figures on "Triptorelin Market - Global forecast to 2026".
